Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors

Dr. Spiegel has been appointed to a leadership role, bringing decades of global clinical-development, regulatory and oncology experience. Her prior Chief Medical Officer positions at Schering-Plough and PTC Therapeutics may strengthen the company's clinical and regulatory capabilities, though no financial terms, trial data, or operating guidance were disclosed.